Bruker to Pocket at Least $14.7M in Stock Offering | GenomeWeb
NEW YORK (GenomeWeb News) — Bruker BioSciences today said it expects to pocket at least $14.7 million after issuing a stock offering.
The company said proceeds from the sale may be used for general purposes, repaying debts, and potential acquisitions. 
The company said it expects to sell 10.4 million shares at $7.10 apiece. Bruker said it expects selling stockholders to earn roughly $54.9 million. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.